| Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis J Quek, KE Chan, ZY Wong, C Tan, B Tan, WH Lim, DJH Tan, ASP Tang, ... The lancet Gastroenterology & hepatology 8 (1), 20-30, 2023 | 386 | 2023 |
| Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19 AV Kulkarni, P Kumar, HV Tevethia, M Premkumar, JP Arab, R Candia, ... Alimentary pharmacology & therapeutics 52 (4), 584-599, 2020 | 286 | 2020 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 221 | 2022 |
| Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities F Idalsoaga, AV Kulkarni, OY Mousa, M Arrese, JP Arab Frontiers in medicine 7, 448, 2020 | 124 | 2020 |
| Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases C Fang, J An, A Bruno, X Cai, J Fan, J Fujimoto, R Golfieri, X Hao, H Jiang, ... Hepatology international 14, 437-453, 2020 | 113 | 2020 |
| Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome C Efe, AV Kulkarni, BT Beretta‐Piccoli, B Magro, A Stättermayer, ... Hepatology 76 (6), 1576-1586, 2022 | 106 | 2022 |
| Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study JP Arab, LA Díaz, N Baeza, F Idalsoaga, E Fuentes-López, J Arnold, ... Journal of hepatology 75 (5), 1026-1033, 2021 | 105 | 2021 |
| Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis EEL Cho, CZ Ang, J Quek, CE Fu, LKE Lim, ZEQ Heng, DJH Tan, WH Lim, ... Gut 72 (11), 2138-2148, 2023 | 95 | 2023 |
| Impact of COVID-19 on liver transplant recipients–A systematic review and meta-analysis AV Kulkarni, HV Tevethia, M Premkumar, JP Arab, R Candia, K Kumar, ... EClinicalMedicine 38, 2021 | 76 | 2021 |
| Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives AV Kulkarni, JP Arab, M Premkumar, C Benítez, S Tirumalige Ravikumar, ... Liver International 40 (12), 2888-2905, 2020 | 64 | 2020 |
| The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease CH Ng, KE Chan, YH Chin, RW Zeng, PC Tsai, WH Lim, DJH Tan, ... Clinical and molecular hepatology 28 (3), 565, 2022 | 61 | 2022 |
| Drugs for non-alcoholic steatohepatitis (NASH): quest for the holy grail M Sharma, M Premkumar, AV Kulkarni, P Kumar, DN Reddy, NP Rao Journal of clinical and translational hepatology 9 (1), 40, 2020 | 59 | 2020 |
| Early liver transplantation after COVID-19 infection: the first report AV Kulkarni, K Parthasarathy, P Kumar, M Sharma, R Reddy, ... American Journal of Transplantation 21 (6), 2279-2284, 2021 | 53 | 2021 |
| SARS‐CoV‐2 infections among patients with liver disease and liver transplantation who received COVID‐19 vaccination AM Moon, GJ Webb, I García‐Juárez, AV Kulkarni, G Adali, DK Wong, ... Hepatology communications 6 (4), 889-897, 2022 | 49 | 2022 |
| Pathogenesis of liver injury in coronavirus disease 2019 P Kumar, M Sharma, A Kulkarni, PN Rao Journal of Clinical and Experimental Hepatology 10 (6), 641, 2020 | 43 | 2020 |
| Omega‐3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute‐on‐chronic liver failure: an open‐label randomized controlled trial AV Kulkarni, L Anand, AK Vyas, M Premkumar, AK Choudhury, ... Journal of gastroenterology and hepatology 36 (7), 1953-1961, 2021 | 41 | 2021 |
| Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes LA Díaz, E Fuentes-López, F Idalsoaga, G Ayares, O Corsi, J Arnold, ... Journal of hepatology 80 (3), 409-418, 2024 | 40 | 2024 |
| Primary norfloxacin prophylaxis for APASL-defined acute-on-chronic liver failure: a placebo-controlled double-blind randomized trial AV Kulkarni, S Tirumalle, M Premkumar, K Kumar, S Fatima, B Rapole, ... Official journal of the American College of Gastroenterology| ACG 117 (4 …, 2022 | 39 | 2022 |
| Pathophysiology and prevention of paracentesis-induced circulatory dysfunction: a concise review AV Kulkarni, P Kumar, M Sharma, TR Sowmya, R Talukdar, PN Rao, ... Journal of clinical and translational hepatology 8 (1), 42, 2020 | 39 | 2020 |
| Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure N Verma, RK Dhiman, A Choudhury, S Taneja, A Duseja, V Singh, ... Hepatology International 15, 970-982, 2021 | 38 | 2021 |
Madhumita PremkumarAssistant Professor, Department of Hepatology, PGIMER, ChandigarhCorreu electrònic verificat a pgimer.edu.in